The controlling shareholder of Actblue Co., Ltd. (300816.SZ) plans to reduce their shareholding by no more than 3%.
Aikolan (300816.SZ) announced that it holds 31.1086 million shares of the company's stock, accounting for the total share capital...
Actblue Co., Ltd. (300816.SZ) announced that its controlling shareholder, actual controller, and chairman Mr. Liu Yi plans to reduce his shareholding by a total of 2.3622 million shares (representing 3% of the total share capital excluding shares held in the repurchase account) through centralized bidding and block trading within three months after 15 trading days from the disclosure of this announcement. Mr. Liu currently holds 31.1086 million shares of the company (38.89% of the total share capital, 39.51% excluding shares held in the repurchase account).
Related Articles
US Stock Market Move | Beigene (ONC.US) rose more than 3%, BTK inhibitors officially put into clinical use in China.
MANSHING GLOBAL (08309) announces annual results with a net loss of HK$7.229 million, a turnaround from profit to loss on a year-on-year basis.
INNOVATIVE PHAR(00399) issues profit warning, expecting a net loss of approximately HK$550 million to HK$600 million for the year.
US Stock Market Move | Beigene (ONC.US) rose more than 3%, BTK inhibitors officially put into clinical use in China.
MANSHING GLOBAL (08309) announces annual results with a net loss of HK$7.229 million, a turnaround from profit to loss on a year-on-year basis.
INNOVATIVE PHAR(00399) issues profit warning, expecting a net loss of approximately HK$550 million to HK$600 million for the year.
